BIOTECHNOLOGY VALUE FUND L P 13D and 13G filings for Repare Therapeutics Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-11-17 4:52 pm Purchase | 2023-11-15 | 13D | Repare Therapeutics Inc. RPTX | BIOTECHNOLOGY VALUE FUND L P | 10,333,600 24.500% | 1,235,000 (+13.57%) | Filing |
| 2023-11-03 5:20 pm Purchase | 2023-11-02 | 13D | Repare Therapeutics Inc. RPTX | BIOTECHNOLOGY VALUE FUND L P | 9,098,600 21.600% | 806,612 (+9.73%) | Filing |
| 2023-02-13 5:55 pm Purchase | 2022-12-31 | 13G | Repare Therapeutics Inc. RPTX | BIOTECHNOLOGY VALUE FUND L P | 8,291,988 19.800% | 150,000 (+1.84%) | Filing |
| 2022-06-06 5:25 pm Purchase | 2022-06-02 | 13G | Repare Therapeutics Inc. RPTX | BIOTECHNOLOGY VALUE FUND L P | 8,141,988 19.400% | 3,283,227 (+67.57%) | Filing |
| 2022-02-11 9:11 pm Purchase | 2021-12-31 | 13G | Repare Therapeutics Inc. RPTX | BIOTECHNOLOGY VALUE FUND L P | 4,858,761 11.600% | 1,136,363 (+30.53%) | Filing |
| 2021-03-16 5:18 pm Purchase | 2021-03-12 | 13G | Repare Therapeutics Inc. RPTX | BIOTECHNOLOGY VALUE FUND L P | 3,722,398 10.100% | 750,207 (+25.24%) | Filing |
| 2021-02-12 4:22 pm Purchase | 2020-12-31 | 13G | Repare Therapeutics Inc. RPTX | BIOTECHNOLOGY VALUE FUND L P | 2,972,191 8.100% | 1,027,645 (+52.85%) | Filing |
| 2020-06-29 6:25 pm Purchase | 2020-06-19 | 13G | Repare Therapeutics Inc. RPTX | BIOTECHNOLOGY VALUE FUND L P | 1,944,546 5.300% | 1,944,546 (New Position) | Filing |